Published on India Environment Portal | News, reports, documents, blogs, data, analysis on environment & development | India, South Asia (http://admin.indiaenvironmentportal.org.in)

Home > News > In new pharma pricing policy, hope beyond bitter pill > In new pharma pricing policy, hope beyond bitter pill

In new pharma pricing policy, hope beyond bitter pill [1]

Analysts say the new mechanism would impact revenues in the short term only

The Indian pharmaceutical industry is likely to see a dip in valuations in the near term as a result of the recent pricing policy that aims to intensify the regulatory hold over essential drugs. Profit of major drug makers, including that of GlaxoSmithKline (GSK) Pharma, Abbott, Cipla, Ranbaxy and Cadila could be hit the most. But, analysts are optimistic that the revenue impact might not last for more than 18 months to two years.

Publication Date: 
21/12/2012
Sushmi Dey [2]
Business Standard (New Delhi) [3]
Tags:
India [4], Drugs [5], Drug Industry [6], Ranbaxy Pharmaceuticals [7], Health [8]

Technology Partners: MimirTech

Source URL: http://admin.indiaenvironmentportal.org.in/news/new-pharma-pricing-policy-hope-beyond-bitter-pill

Links:
[1] http://admin.indiaenvironmentportal.org.in/news/new-pharma-pricing-policy-hope-beyond-bitter-pill
[2] http://admin.indiaenvironmentportal.org.in/category/author/sushmi-dey
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/business-standard-new-delhi
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ranbaxy-pharmaceuticals
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health